Clinical trial
Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary…
NCT00480636 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00480636 |
|---|---|
| Title | Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients |
| Official title | Fragmin Safety And Efficacy In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism And Extended Thromboprophylaxis In Cancer Patients In Slovakia (An Open, Prospective, Non-Comparative Study) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Acute Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | Fragmin (dalteparin sodium ) |
| Enrollment | 102 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | May 31, 2007 |
| Last update posted | Aug 10, 2010 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: